Number medications
Showing 1 - 25 of >10,000
Type 2 Diabetes Trial in Worldwide (Insulin Glargine (HOE901 - U300), Insulin Glargine (HOE901 - U100), Background therapy)
Completed
- Type 2 Diabetes Mellitus
- Insulin Glargine (HOE901 - U300)
- +2 more
-
Saraland, Alabama
- +161 more
Apr 10, 2020
Polypharmacy, Dementia, Quality of Life Trial (Shed-MEDS deprescribing intervention)
Not yet recruiting
- Polypharmacy
- +2 more
- Shed-MEDS deprescribing intervention
- (no location specified)
Jul 18, 2023
Deprescriptions, Aged, Inappropriate Prescribing Trial in Subang Jaya (MALPIP criteria)
Not yet recruiting
- Deprescriptions
- +4 more
- MALPIP criteria
-
Subang Jaya, Selangor, MalaysiaShaun Lee
May 25, 2023
Elearning for Children and Young People With Asthma
Completed
- Asthma
-
Sheffield, United KingdomClinical Research Facility, Sheffield Childrens Hospital
Jul 24, 2023
Bleeding Complications Trial in Rochester (Clopidogrel, Prasugrel, Tricagrelor)
Active, not recruiting
- Bleeding Complications
- Clopidogrel
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 31, 2022
Polypharmacy Trial in Oakland (Bundled hyperpolypharmacy)
Active, not recruiting
- Polypharmacy
- Bundled hyperpolypharmacy
-
Oakland, CaliforniaKaiser Permanente Division of Research
Nov 14, 2022
Medication Errors Trial in Malmö (Intervention for correct discharge medication list)
Recruiting
- Medication Errors
- Intervention for correct discharge medication list
-
Malmö, SwedenSkåne University Hospital
Mar 14, 2023
HIV, Alcohol Use Trial (IMB-motivational interviewing (MI) techniques (IMB-MI))
Not yet recruiting
- HIV
- Alcohol Use
- IMB-motivational interviewing (MI) techniques (IMB-MI)
- (no location specified)
Dec 2, 2022
Aging Trial in Southampton (Structured multidisciplinary medication review)
Recruiting
- Aging
- Structured multidisciplinary medication review
-
Southampton, United KingdomClinical Research Network in Primary Care
Jan 26, 2023
Medication Adverse Effects Trial (Patient-tailored deprescribing assessment and intervention)
Not yet recruiting
- Medication Adverse Effects
- Patient-tailored deprescribing assessment and intervention
- (no location specified)
Oct 26, 2023
Opioid Use Disorder, Sleep Disturbance Trial in Birmingham (Post-Illumination Pupillary Response (PIPR), Polysomnography,
Not yet recruiting
- Opioid Use Disorder
- Sleep Disturbance
- Post-Illumination Pupillary Response (PIPR)
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Oct 24, 2023
Polypharmacy Trial in Leuven (Medication review and discharge counseling)
Withdrawn
- Polypharmacy
- Medication review and discharge counseling
-
Leuven, BelgiumUZLeuven
Apr 13, 2023
Hepatitis C Pharmacy-based Strategy for Injectors
Active, not recruiting
- Hepatitis C
-
Seattle, WashingtonUniversity of Washington
May 1, 2022
Glaucoma Trial in Tehran (Adjunctival Triamcinolone)
Completed
- Glaucoma
- Adjunctival Triamcinolone
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Jun 12, 2022
Glaucoma, Cataract Trial in Tehran (Non-penetrating deep sclerectomy and phacoemulsification and autotransplantation of anterior
Active, not recruiting
- Glaucoma
- Cataract
- Non-penetrating deep sclerectomy and phacoemulsification and autotransplantation of anterior lens capsule
- Non-penetrating deep sclerectomy and phacoemulsification
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Jun 7, 2023
Asthma in Children Trial (SB-CAP)
Not yet recruiting
- Asthma in Children
- SB-CAP
- (no location specified)
Feb 15, 2023
Geriatric Assessment, Frail Elderly, Skilled Nursing Facilities Trial in Nashville (Deprescribing intervention)
Active, not recruiting
- Geriatric Assessment
- +3 more
- Deprescribing intervention
-
Nashville, TennesseeTennessee Valley Healthcare System Nashville Campus, Nashville,
Jan 4, 2023
Healthcare Resource Utilisation, Common Mental Health Problems,
Completed
- Inflammatory Bowel Diseases
- +2 more
- No intervention
-
London, United KingdomMomentum Data Ltd
Dec 13, 2022
Peripheral Artery Disease, Peripheral Vascular Disease Trial in Palo Alto (High PAD risk Alert)
Not yet recruiting
- Peripheral Artery Disease
- Peripheral Vascular Disease
- High PAD risk Alert
-
Palo Alto, CaliforniaStanford University
Jul 11, 2022
Breast Cancer Trial in New York (Multicomponent Adherence Intervention)
Recruiting
- Breast Cancer
- Multicomponent Adherence Intervention
-
New York, New YorkColumbia University Medical Center
Nov 6, 2023
Learn About Interferon-beta Exposure of Pregnant Women During
Not yet recruiting
- Multiple Sclerosis (MS)
- Avonex (IFNβ-1-a, Biogen Netherlands B.V)
- +5 more
-
Multiple Locations, Finland
- +1 more
Sep 19, 2023
Concomitant Medications at CML Diagnosis
Completed
- Chronic Myeloid Leukemia
- the prevalence of comorbid conditions
- (no location specified)
Sep 16, 2023
Deprescribing Anticholinergic and Sedative Medications, Physical Function Trial (Deprescribing anticholinergic and sedative
Not yet recruiting
- Deprescribing Anticholinergic and Sedative Medications
- Physical Function
- Deprescribing anticholinergic and sedative mediications
- (no location specified)
Feb 9, 2023
Pain, Postoperative Trial in Stanford (Norco 5Mg-325Mg Tablet, Tylenol 325Mg Caplet, Ibuprofen 200 mg)
Enrolling by invitation
- Pain, Postoperative
- Norco 5Mg-325Mg Tablet
- +2 more
-
Stanford, CaliforniaFacial Plastic and Reconstructive Surgery Clinic
May 5, 2022
Type 2 Diabetes (Adult Onset), Medication Adherence Trial in Boston (REACH-Es, ETAU)
Not yet recruiting
- Type 2 Diabetes (Adult Onset)
- Medication Adherence
- REACH-Es
- ETAU
-
Boston, MassachusettsMassachusetts General Hospital Diabetes Research Center
Aug 15, 2023